Atlas Trials

Pilot Study of Cetuximab and the Hedgehog Inhibitor IPI-926 in Recurrent Head and Neck Cancer

Clinical trial NCT01255800 · COMPLETED

Trial details

NCT number
NCT01255800
Sponsor
University of Colorado, Denver
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Recurrent Head and Neck Cancer
Start date
2011-04-01
Primary completion
2013-12-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.